
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
REVIEW article
Front. Immunol. , 03 March 2022
Sec. Autoimmune and Autoinflammatory Disorders
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.839945
A retraction of this article was approved in:
Retraction: Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies
Citation: Shomali N, Suliman Maashi M, Baradaran B, Daei Sorkhabi A, Sarkesh A, Mohammadi H, Hemmatzadeh M, Marofi F, Sandoghchian Shotorbani S and Jarahian M (2022) Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies. Front. Immunol. 13:839945. doi: 10.3389/fimmu.2022.839945
Received: 20 December 2021; Accepted: 14 February 2022;
Published: 03 March 2022; Retracted: 04 September 2023.
Edited by:
Maria I. Bokarewa, University of Gothenburg, SwedenReviewed by:
Amir Sharabi, Beth Israel Deaconess Medical Center and Harvard Medical School, United StatesDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.